首页> 外文期刊>Mediators of inflammation >Regulation of corticotropin releasing hormone receptor type 1 messenger RNA level in Y-79 retinoblastoma cells: potential implications for human stress response and immune/inflammatory reaction
【24h】

Regulation of corticotropin releasing hormone receptor type 1 messenger RNA level in Y-79 retinoblastoma cells: potential implications for human stress response and immune/inflammatory reaction

机译:Y-79视网膜母细胞瘤细胞中促肾上腺皮质激素释放激素受体1型信使RNA水平的调节:对人类应激反应和免疫/炎症反应的潜在影响

获取原文
           

摘要

We report the regulation of type 1 receptor mRNA in Y-79 human retinoblastoma cells, grown in the absence or presence of pharmacological levels of phorbol esters, forskolin, glucocorticoids and their combinations. To control for inducibility and for assessing the sensitivity of the Y-79 system to glucocorticoids, corticotropin releasing hormone mRNA levels were measured in parallel. All treatments stimulated corticotropin releasing hormone receptor type 1 gene expression relative to baseline. A weak suppression of corticotropin releasing hormone mRNA level was observed during dexamethasone treatment. The cell line expressed ten-fold excess of receptor to ligand mRNA under basal conditions. The findings predict the presence of functional phorbol ester, cyclic AMP and glucocorticoid response elements in the promoter region of corticotropin releasing hormone receptor type 1 gene and support a potential role for its product during chronic stress and immune/inflammatory reaction.
机译:我们报告Y-79人视网膜母细胞瘤细胞中生长的1型受体mRNA的调节,生长在没有佛波酯,佛司可林,糖皮质激素及其组合的药理水平的情况下。为了控制诱导性和评估Y-79系统对糖皮质激素的敏感性,并行测量了促肾上腺皮质激素释放激素mRNA的水平。所有治疗均刺激促肾上腺皮质激素释放相对于基线的1型激素受体基因表达。在地塞米松治疗期间观察到促肾上腺皮质激素释放激素mRNA水平的弱抑制。在基础条件下,该细胞系表达的受体配体mRNA过量十倍。这些发现预示着功能性佛波酯,环状AMP和糖皮质激素反应元件存在于促肾上腺皮质激素释放激素受体1型基因的启动子区域,并在慢性应激和免疫/炎症反应中支持其产物的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号